BRD4 anticorps (acLys332)

N° du produit ABIN7265944

Cet anticorps Lapin Polyclonal détecte spécifiquement BRD4 dans WB. Il présente une réactivité envers Humain.

Aperçu rapide pour BRD4 anticorps (acLys332) (ABIN7265944)

Antigène: BRD4 (Bromodomain Containing 4 (BRD4))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp BRD4 est non-conjugé

Application: Western Blotting (WB)

Détail du produit anti-BRD4 anticorps

Épitope: acLys332

Fonction: Acetyl-BRD4-K332 Rabbit pAb

Réactivité croisée: Humain, Souris

Attributs du produit: Acetylated Antibodies

Purification: Affinity purification

Immunogène: A synthetic acetylated peptide around K332 of human Acetyl-BRD4-K332.

Isotype: IgG

Information d'application

Indications d'application: WB,1:500 - 1:2000

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C. Avoid freeze / thaw cycles.

Détails sur BRD4

Antigène: BRD4 (Bromodomain Containing 4 (BRD4))

Autre désignation: BRD4

Sujet: The protein encoded by this gene is homologous to the murine protein MCAP, which associates with chromosomes during mitosis, and to the human RING3 protein, a serine/threonine kinase. Each of these proteins contains two bromodomains, a conserved sequence motif which may be involved in chromatin targeting. This gene has been implicated as the chromosome 19 target of translocation t(15,19)(q13,p13.1), which defines an upper respiratory tract carcinoma in young people. Two alternatively spliced transcript variants have been described.,BRD4,CAP,HUNK1,HUNKI,MCAP,Epigenetics & Nuclear Signaling,Cancer,Tumor suppressors,Signal Transduction,Kinase,Serine/threonine kinases,BRD4

Poids moléculaire: 80kDa/88kDa/152kDa

ID gène: 23476

UniProt: O60885

Pathways: Chromatin Binding, SARS-CoV-2 Protein Interactome